Search Results - "García de Diego, O"
-
1
Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions and emergency room visits. 66 months of follow-up
Published in European psychiatry (01-03-2023)“…IntroductionPaliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and…”
Get full text
Journal Article -
2
Exactitud y concordancia entre glucómetros: un estudio en condiciones habituales de práctica clínica
Published in Semergen, medicina de familia (01-01-2017)“…Resumen Introducción Los glucómetros demuestran habitualmente una gran exactitud, y en la práctica, la glucemia capilar y la glucemia plasmática (GP) son…”
Get full text
Journal Article -
3
Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen. A 24 months follow-up and mirror image study
Published in European psychiatry (01-08-2024)“…IntroductionRelapse prevention is crucial in patients with schizophrenia, as repeated episodes can worsen psychopathology and functionality. There is strong…”
Get full text
Journal Article -
4
Accuracy and reliability between glucose meters: A study under normal clinical practice conditions
Published in Semergen, medicina de familia (01-01-2017)“…The glucose meters usually show a high accuracy, and in clinical practice, capillary and plasma glucose (PG) are used interchangeably. However, many variables…”
Get full text
Journal Article -
5
Alternative initiation regimen of paliperidone palmitate long-acting injectable
Published in European psychiatry (01-06-2022)“…IntroductionLong-acting injectable antipsychotics (LAIs) hold an important place in the treatment of psychosis. Knowledge of the best way to administer LAIs is…”
Get full text
Journal Article -
6
Efficacy of paliperidone palmitate 3-month formulation in preventing hospital admissions. 60 months of follow-up
Published in European psychiatry (01-06-2022)“…IntroductionPaliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and…”
Get full text
Journal Article -
7
Efficacy and tolerability Aripiprazole once-monthly long-acting injectable in schizophrenia. Two-injection start regimen
Published in European psychiatry (01-06-2022)“…IntroductionAripiprazole once-monthly is a long-acting intramuscular injectable formulation of aripiprazole. The starting dose can be administered by following…”
Get full text
Journal Article